Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications (Clinical Research in Cardiology, (2023), 112, 3, (419-430), 10.1007/s00392-022-02126-8)

Vincenzo Nuzzi, Antonio Cannatà, Pierpaolo Pellicori, Paolo Manca, Davide Stolfo, Caterina Gregorio, Giulia Barbati, Daniel I. Bromage, Theresa McDonagh, John G.F. Cleland, Marco Merlo*, Gianfranco Sinagra

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Abstract

Within the abstract, the following phrase in the ‘Methods’ section “According to FED trajectory, patients were classified as (i) dose (FED increase by ≥ 50% or newly initiated);” was corrected to read “According to FED trajectory, patients were classifed as (i) dose ↑ (FED increase by ≥ 50% or newly initiated);”. In the ‘Results’ section of the abstract, the sentence“Baseline FED was independently associated with outcome (HR per 20 mg increase: 1.12 [95% CI 1.04–1.22, p = 0.003].” was corrected to “Baseline FED was independently associated with outcome (HR per 20 mg increase: 1.12 [95% CI 1.04–1.22], p = 0.003).” Finally, in Table 1, the LVEF, % for Dose↓ patients was given incorrectly when it should have been “28 (22–34)” and the N value has been corrected from “263” to “282”. The original article has been corrected.

Original languageEnglish
Pages (from-to)454
Number of pages1
JournalClinical Research in Cardiology
Volume112
Issue number3
DOIs
Publication statusPublished - 6 Dec 2022

Fingerprint

Dive into the research topics of 'Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications (Clinical Research in Cardiology, (2023), 112, 3, (419-430), 10.1007/s00392-022-02126-8)'. Together they form a unique fingerprint.

Cite this